Evidence map›Paper›PMID 36690069›Full record

ArticleJournal of molecular biology2023

Interactions between FUS and the C-terminal Domain of Nup62 are Sufficient for their Co-phase Separation into Amorphous Assemblies.

Meenakshi Sundaram Kumar, Karly M Stallworth, Anastasia C Murthy, Su Min Lim, Nan Li, Aastha Jain, James B Munro, Nicolas L Fawzi, Clotilde Lagier-Tourenne, Daryl A Bosco

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Meenakshi Sundaram KumarDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA; Biochemistry and Molecular Biotechnology Program, Morningside Graduate School of Biomedical Sciences, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Karly M StallworthDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA.
Anastasia C MurthyDepartment of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, USA.
Su Min LimDepartment of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Nan LiDepartment of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Aastha JainDepartment of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
James B MunroDepartment of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Nicolas L FawziDepartment of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, USA.
Clotilde Lagier-TourenneDepartment of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Daryl A BoscoDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA. Electronic address: Daryl.Bosco@umassmed.edu.
University of Massachusetts Chan Medical School · USBroad Institute · USBrown University · US

Funding

Multimodal analysis and therapeutic targeting of aberrant nucleocytoplasmic compartmentalization in FUS-related neurodegenerative diseaseR01NS108769 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Daryl Angela Bosco, Ankur Jain · 2019 to 2026
$5.2M
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1R01GM137529 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOSCO, DARYL ANGELA, MASSI, FRANCESCA · 2021 to 2024
$2.1M
Residue-by-residue details of FUS protein phase separation and aggregationR01GM147677 · NIGMS · BROWN UNIVERSITY · PI FAWZI, NICOLAS LUX · 2022 to 2025
$1.7M
Turning off the molecular switch for pathological self-assembly of FUSR01GM118530 · NIGMS · BROWN UNIVERSITY · PI FAWZI, NICOLAS LUX · 2016 to 2020
$1.6M
Role of p38alpha signaling in mutant SOD1-linked motor neuron diseaseR21NS120126 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOSCO, DARYL ANGELA, MORFINI, GERARDO ANDRES · 2020 to 2020
$458k
NIGMS NIH HHS R01 GM118530NIGMS NIH HHS R01 GM137529NIGMS NIH HHS R01 GM147677NINDS NIH HHS R01 NS108769NINDS NIH HHS R21 NS120126
6 · The paper itself

Abstract

Deficient nucleocytoplasmic transport is emerging as a pathogenic feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), including in ALS caused by mutations in Fused in Sarcoma (FUS). Recently, both wild-type and ALS-linked mutant FUS were shown to directly interact with the phenylalanine-glycine (FG)-rich nucleoporin 62 (Nup62) protein, where FUS WT/ Nup62 interactions were enriched within the nucleus but ALS-linked mutant FUS/ Nup62 interactions were enriched within the cytoplasm of cells. Nup62 is a central channel Nup that has a prominent role in forming the selectivity filter within the nuclear pore complex and in regulating effective nucleocytoplasmic transport. Under conditions where FUS phase separates into liquid droplets in vitro, the addition of Nup62 caused the synergistic formation of amorphous assemblies containing both FUS and Nup62. Here, we examined the molecular determinants of this process using recombinant FUS and Nup62 proteins and biochemical approaches. We demonstrate that the structured C-terminal domain of Nup62 containing an alpha-helical coiled-coil region plays a dominant role in binding FUS and is sufficient for inducing the formation of FUS/Nup62 amorphous assemblies. In contrast, the natively unstructured, F/G repeat-rich N-terminal domain of Nup62 modestly contributed to FUS/Nup62 phase separation behavior. Expression of individual Nup62 domain constructs in human cells confirmed that the Nup62 C-terminal domain is essential for localization of the protein to the nuclear envelope. Our results raise the possibility that interactions between FUS and the C-terminal domain of Nup62 can influence the function of Nup62 under physiological and/or pathological conditions.

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal DementiaMembrane GlycoproteinsNuclear Pore Complex ProteinsProtein Interaction Domains and MotifsRNA-Binding Protein FUSActive Transport, Cell NucleusCytoplasmHumansMutationFUS protein, humanMembrane GlycoproteinsNuclear Pore Complex Proteinsnuclear pore protein p62RNA-Binding Protein FUSamyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)fused in sarcoma (FUS)nucleocytoplasmic transportnucleoporin 62 (Nup62)phase separation

Identifiers

PMID36690069
PMCPMC10329203
OpenAlexW4317569115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.